Research ArticleArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor
Ping-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology November 2006, 70 (5) 1534-1541; DOI: https://doi.org/10.1124/mol.106.023911
Ping-Hui Tseng
Yu-Chieh Wang
Shu-Chuan Weng
Jing-Ru Weng
Chang-Shi Chen
Robert W. Brueggemeier
Charles L. Shapiro
Ching-Yu Chen
Sandra E. Dunn
Michael Pollak

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor
Ping-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology November 1, 2006, 70 (5) 1534-1541; DOI: https://doi.org/10.1124/mol.106.023911
Research ArticleArticle
Overcoming Trastuzumab Resistance in HER2-Overexpressing Breast Cancer Cells by Using a Novel Celecoxib-Derived Phosphoinositide-Dependent Kinase-1 Inhibitor
Ping-Hui Tseng, Yu-Chieh Wang, Shu-Chuan Weng, Jing-Ru Weng, Chang-Shi Chen, Robert W. Brueggemeier, Charles L. Shapiro, Ching-Yu Chen, Sandra E. Dunn, Michael Pollak and Ching-Shih Chen
Molecular Pharmacology November 1, 2006, 70 (5) 1534-1541; DOI: https://doi.org/10.1124/mol.106.023911